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Early Descriptions of Possible Angina Pectoris
Notwithstanding the conditions prevailing before the eighteenth century, there
were undoubtedly some few individuals who had the potential for development of
ischaemic heart disease. This can occur in the absence ofexogenous risk factors for
coronary arteriosclerosis, for example, in rare homozygous subjects with familial
abnormalities of cholesterol metabolism.3 Congenital coronary arterial anomalies
can also very occasionally cause angina independently of arteriosclerotic disease.4
Either of these could have accounted for Heberden's twelve-year-old patient with
exertional chest pain. The present work does not therefore attempt to prove that
angina pectoris was a totally new syndrome emerging in the mid-eighteenth century
in the way, for example, that Acquired Immune Deficiency Syndrome (AIDS) first
became manifest in the late 1970s. It isbeing suggested thatbefore themid-eighteenth
century angina pectoris was too rare to have been recognisable as a distinct clinical
entity by any one physician.
3 Peter H Jones and Antonio M Gotto, 'Assessment of lipid abnormalities in the heart', in J Willis
Hurst and Richard C Schlant (eds), The heart, arteries and veins, 7th ed., New York, McGraw Hill, 1990,
p. 378.
4J Noble et at., 'Myocardial bridging and milking effect of the left anterior coronary artery. Normal
variant or obstruction?', Am J Cardiol. 1976. 37: 993-9. p. 997.
Coronary Heart Disease Frequency in the Absence of Traditional Risk Factors
In mid-twentieth century studies, the frequency of symptomatic coronary heart
disease occurring in the then apparent absence of risk factors may have been
overestimated. When the association of lipid abnormalities with increased risk of
coronary arterial disease was first recognized, "normality" of serum cholesterol was
based on results of measurements that were made in apparently healthy subjects.
Levels that were then accepted as normal would now be regarded as pathologically
high and a consequence of the excessively fatty diets and possibly resulting obesity
that has been all too common in western societies. As late as 1998, the CARE
study, an investigation of the effect of pravastatin (a cholesterol lowering medica-
tion) on the incidence of coronary events among survivors of a first myocardial
infarction was initiated because total serum cholesterol levels in the range of 5.2 to
6.2 mmol/L were then considered to be unproven as risk factors and therefore
regarded as normal. Indeed the ethical decision to allow randomizing halfthe study
population to placebo treatment was based on this premise. The term hyper-
cholesterolaemia was reserved for levels above 6.2 mmol/L. The results ofthe CARE
study itself showed that serum cholesterol concentrations earlier categorized as
"average" should now be considered pathologically high, even 5.2 mmol/L being
considered excessive.5
A measure of the incidence of overt coronary heart disease in populations with
total serum cholesterol levels that are acceptable as normal by present standards
5F M Sacksetal., 'Relationship betweenplasma LDLconcentrationsduringtreatmentwithpravastatin
and recurrent coronary events in the Cholesterol and Recurrent Events trial', Circulation, 1998, 15:
1446-52, p. 1447.
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can be derived from a number of epidemiologic studies. Among the most valuable
is the MRFIT study which involved a six-year follow-up of over one-third of a
million American males who were between thirty-five and fifty-seven years ofage at
entry and free ofknown coronary heart disease. The published results include reports
of CHD death rates among a subgroup of men who did not smoke cigarettes
and had low serum total cholesterol levels. This would have a direct bearing on
circumstances that prevailed before the beginnings of the Agricultural Revolution
when diets were perforce deficient in animal fats and cigarettes unknown. There
were 45,353 such men in the MRFIT study who had initial total serum cholesterol
levels below 4.68 mmol/L. Of these, 83 died as a result ofcoronary heart disease, a
yearly rate of about 0.30 per thousand.6 The United States findings have been
paralleled by observations in China where Zhenming Chen and his colleagues
studied 6,494 men and 2,857 women. They were observed for eight to thirteen years
and their ages ranged from thirty-five to sixty-four years at recruitment. In a 2,162
subsection of these subjects the initial total serum cholesterol was below
3.53 mmol/L, their mean being 3.08. During the period of observation, there were
four coronary heart disease deaths, which, assuming an average follow-up ofabout
ten years, gives a death rate of roughly 0.18 per thousand per year.7 Although
smokers were not excluded from the study, this incidence is little more than halfthe
rate observed in the USA investigation, the lower initial serum cholesterol level used
to define the Chinese group possibly accounting for the difference. Both the MRFIT
and the Chinese studies were initiated before treatment had made any appreciable
impact on mortality. They both suggest therefore that a population living before the
onset of the Agricultural Revolution and having perforce a low fat diet could well
have been subject to comparable death rates from coronary heart disease, i.e. between
0.18 and 0.30 per thousand per year.
These low incidence rates suggest that when the serum total cholesterol levels are
low, other recently recognised risk factors have little epidemiological significance
(see page 74). As an example, Meir Stampfer and others conducted a prospective
study ofthe relation ofplasma homocysteine levels to risk ofmyocardial infarction.
This amino acid is associated with premature arterial disease when present in excess.
In what ultimately proved to be a low risk group generally, 14,916 male American
physicians aged forty to eighty-four years at entry and with no prior infarction or
stroke were followed for five years. Among patients with homocysteine levels in the
95th upper percentile or higher there were thirty-one cases, scarcely 0.2 per cent of
the total population at risk.8 Lp(a) also appears to be of doubtful importance as a
risk factor when other lipid levels are low.9 The same is true of coagulation and
6Jeremiah Stamler, Deborah Wentworth and James D Neaton, 'Is relationship between serum
cholesterol and risk of premature death from coronary heart disease continuous and graded?', JAMA,
1986, 256: 2823-8, p. 2825.
7Zhenming Chen et al., 'Serum cholesterol and coronary heart disease in a population with low
cholesterol concentrations', Br Med J, 1991, 303: 276-82, p. 279.
8Meir Stampfer etal., 'A prospective study ofplasma homocyst(e)ine and risk ofmyocardial infarction
in US physicians', JAMA, 1992, 268: 877-81, p. 879.
9Bernard Cantin et al., 'Is lipoprotein (a) an independent risk factor for ischemic heart disease in
men? The Quebec cardiovascular study', J Am Coll Cardiol, 1998, 31: 519-25, p. 521.
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clotting functions. Thus G J Miller and co-workers found that when fat intake is
low factor VII concentration is reduced'" and in addition the impact of fibrinogen
on CHD incidence has been found to be lower when serum LDL cholesterol levels
are relatively low."
If the 0.18 to 0.30 per thousand annual mortality reported in the Chinese and
MRFIT studies is any indication, other manifestations of CHD such as angina
pectoris could also be presumed to have been infrequent. A general physician would
need to wait for years and see several thousand patients before finding a single case.
This would have been the situation of the eighteenth-century doctor who was a
general practitioner in the fullest sense, attending adults and children, men and
women, young and old, victims of trauma, and patients with psychiatric as well as
organic diseases. Recognition of a distinctive syndrome requires seeing, preferably
not too far apart in time, some minimum number of patients with similar clinical
features. Before 1768 Heberden saw patients with the typical chest pain on exertion
with a frequency that averaged about once a year, and it was only after he had
experience ofa total of twenty that he could group these subjects together, showing
as they did common features of a condition concerning which he "could find no
satisfaction from books".'2 It is therefore understandable that a much greater rarity
ofangina pectoris in an earlier era could have precluded its recognition as a distinct
condition by even the most observant of clinicians.
'0G J Miller et al., 'Fat consumption and factor VII coagulant activity in middle aged men. An
association between a dietary and thrombogenic coronary risk factor', Arteriosclerosis, 1989, 78: 19-24,
p. 21.
"Jurgen Heinrich et al., 'Fibrinogen and factor VII in the prediction ofcoronary risk. Results from
the PROCAM study in healthy men', Arterioscier Thromb, 1994, 14: 54-9, p. 56.
12William Heberden, 'Some account of a disorder in the breast', Med Trans Coll Physns Lond, 1772,
2: 59-67, pp. 59-64. 62.
Pathological Evidence of Coronary Arterial and Heart Disease before 1768
Arterial calcification has been described in Egyptian mummies, the earliest about
thirty-five centuries old and the most notable that of the Pharaoh Menephtah. The
incidence is of course unknown and observations were confined for the most part
to the large arteries and to the aorta in particular.'3 Arteriosclerosis however is now
known to be a diffuse process and the association of aortic with coronary arterial
calcification is well recognized. Moreover, fibrous thickening of coronary arterial
walls has been reported in a 3,000-year-old female mummy,'4 and "roughened"
arteries were described in Bonet's Sepulchretum in 1679.'5 Twenty-nine years later
"ossification" was observed in the coronary arteries by Thebesius, better known
for the eponymously named veins and valves in the heart.'6 Coronary arterial
3H T Blumenthal (ed.), Cowdry's arteriosclerosis: a survey ofthe problem, 2nd ed., Springfield, ILL,
Thomas, 1967, p. 6.
'4Allen R Long, 'Cardiovascular renal disease. Report of a case three thousand years ago', Arch
Pathol, 1931, 12: 92-4.
'5T Bonet, Sepulchretum sive anatomia practica ex cadaveribus morbo denatis, Geneva, Chouet, 1679,
p. 387.
16J 0 Leibowitz, The history ofcoronary heart disease, London, Wellcome Institute of the History of
Medicine, 1970, p. 74.
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